InvestLog
CCCC logo

CCCC

C4 Therapeutics, Inc.NASDAQHealthcare
$2.82+4.44%ClosedMarket Cap: $233.6M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-27Barclays—Overweight—
2026-02-23Brookline Capital—Buy—
2025-12-17Barclays—Overweight—
2025-09-23Wells Fargo—Overweight—
2025-09-23Barclays—Overweight—
2025-09-22Stephens & Co.—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.99$21.6M4
Sun Dec 31$-1.29$29.1M6
Mon Dec 31$0.33$623.6M4
Tue Dec 31$4.03$1.99B2